Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal - The New York Times

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal  The New York Times

The drugmaker AbbVie said on Tuesday that it planned to buy Allergan, the maker of Botox, for about $63 billion, in one of the biggest mergers in the health care ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases